Prescription Drug Monitoring Programs: Promising Practices in Need of Refinement

被引：15
作者：
Compton, Wilson M. [1 ,2 ]
Wargo, Eric M. [1 ]
机构：
[1] NIDA, 6001 Execut Blvd, Bethesda, MD 20892 USA
[2] 6001 Execut Blvd,MSC 9581, Bethesda, MD 20892 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2018年 / 168卷 / 11期
关键词：
UNITED-STATES; HEROIN;
D O I：
10.7326/M18-0883
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：826 / +
页数：3
相关论文
共 50 条
  • [41] The Use of a Prescription Drug Monitoring Program to Develop Algorithms to Identify Providers With Unusual Prescribing Practices for Controlled Substances
    Ringwalt, Christopher
    Schiro, Sharon
    Shanahan, Meghan
    Proescholdbell, Scott
    Meder, Harold
    Austin, Anna
    Sachdeva, Nidhi
    JOURNAL OF PRIMARY PREVENTION, 2015, 36 (05) : 287 - 299
  • [42] Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses
    Cerda, Magdalena
    Ponicki, William R.
    Smith, Nathan
    Rivera-Aguirre, Ariadne
    Davis, Corey S.
    Marshall, Brandon D. L.
    Fink, David S.
    Henry, Stephen G.
    Castillo-Carniglia, Alvaro
    Wintemute, Garen J.
    Gaidus, Andrew
    Gruenewald, Paul J.
    Martins, Silvia S.
    EPIDEMIOLOGY, 2020, 31 (01) : 32 - 42
  • [43] The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey
    Pomerleau, Adam C.
    Nelson, Lewis S.
    Hoppe, Jason A.
    Salzman, Matthew
    Weiss, Paul S.
    Perrone, Jeanmarie
    PAIN MEDICINE, 2017, 18 (05) : 889 - 897
  • [44] Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10US States
    Moyo, Patience
    Simoni-Wastila, Linda
    Griffin, Beth Ann
    Onukwugha, Eberechukwu
    Harrington, Donna
    Alexander, G. Caleb
    Palumbo, Francis
    ADDICTION, 2017, 112 (10) : 1784 - 1796
  • [45] Cross-sectional analysis of national testosterone prescribing through prescription drug monitoring programs, 2018-2022
    Selinger, Scott
    Thallapureddy, Aneesh
    PLOS ONE, 2024, 19 (08):
  • [46] Provider beliefs on the Barriers and Facilitators to Prescription Monitoring Programs and Mandated Use
    Reist, Jeff
    Frazier, Joseph
    Rottingham, Alecia
    Welsh, Mackenzie
    Viyyuri, Brahmendra Reddy
    Witry, Matthew
    SUBSTANCE USE & MISUSE, 2020, 55 (01) : 1 - 11
  • [47] Influence of prescription monitoring programs on analgesic utilization by an insured retiree population
    Simoni-Wastila, Linda
    Qian, Jingjing
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (12) : 1261 - 1268
  • [48] Surveillance, Self-Governance, and Mortality: The Impact of Prescription Drug Monitoring Programs on US Overdose Mortality, 2000-2016
    Vuolo, Mike
    Frizzell, Laura C.
    Kelly, Brian C.
    JOURNAL OF HEALTH AND SOCIAL BEHAVIOR, 2022, 63 (03) : 337 - 356
  • [49] Psychosocial Correlates of Clinicians' Prescription Drug Monitoring Program Utilization
    Pugliese, John A.
    Wintemute, Garen J.
    Henry, Stephen G.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2018, 54 (05) : E91 - E98
  • [50] A description of Medical Examiner prescription-related deaths and prescription drug monitoring program data
    Lev, Roneet
    Petro, Sean
    Lee, Oren
    Lucas, Jonathan
    Stuck, Amy
    Vilke, Gary M.
    Castillo, Edward M.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (03) : 510 - 514
12345